Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma
- 1 December 2009
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 22 (12), 1541-1547
- https://doi.org/10.1038/modpathol.2009.149
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasmsLaboratory Investigation, 2008
- Formation of the 12q14-q15 Amplicon Precedes the Development of a Well-differentiated Liposarcoma Arising From a nonchondroid Pulmonary HamartomaThe American Journal of Surgical Pathology, 2006
- Differential Gene Expression in Liposarcoma, Lipoma, and Adipose TissueCancer Investigation, 2005
- Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomasInternational Journal of Cancer, 2004
- Characterization of centromere alterations in liposarcomasGenes, Chromosomes and Cancer, 2000
- The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cellsHuman Genetics, 1999
- Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumorsGenes, Chromosomes and Cancer, 1999
- DISTINCT mdm2/p53 EXPRESSION PATTERNS IN LIPOSARCOMA SUBGROUPS: IMPLICATIONS FOR DIFFERENT PATHOGENETIC MECHANISMSThe Journal of Pathology, 1997
- Separate amplified regions encompassingCDK4 andMDM2 in human sarcomasGenes, Chromosomes and Cancer, 1996
- Characterization of the 12q13-15 amplicon in soft tissue tumorsCancer Genetics and Cytogenetics, 1995